Bryant Rosalind, Porter Jerlym S, Sobota Amy
Baylor College of Medicine/Texas Children's Hospital, Houston, TX, USA
St. Jude Children's Research Hospital, Memphis, TN, USA.
J Pediatr Oncol Nurs. 2015 Nov-Dec;32(6):355-9. doi: 10.1177/1043454215591954.
With advances in medical care, the majority of children with sickle cell disease are surviving to adulthood. Patients, families, and providers now face the need for this growing population to move from pediatric- to adult-focused care. In order to facilitate a successful transfer to adult health care, and prepare young adults for greater independence, it is recommended that all pediatric patients with sickle cell disease receive transition preparation.
As the professional voice of pediatric hematology/oncology healthcare practice, the Association of Pediatric Hematology/Oncology Nurses (APHON) and the American Society of Pediatric Hematology Oncology (ASPHO) recommends that the discussion of transition begin early and is presented as part of the natural process of becoming an adult; that patients, providers, and families are all involved in creating a transition plan and assessing transition preparedness annually; and that transfer of care involve direct communication between the pediatric team and the accepting adult provider.
随着医疗护理的进步,大多数镰状细胞病患儿都能活到成年。患者、家庭和医疗服务提供者现在面临着让这一不断增长的群体从以儿科为主的护理转向以成人为主的护理的需求。为了促进顺利过渡到成人医疗保健,并让年轻人为更大程度的独立做好准备,建议所有患有镰状细胞病的儿科患者接受过渡准备。
作为儿科血液学/肿瘤学医疗实践的专业声音,儿科血液学/肿瘤学护士协会(APHON)和美国儿科血液学/肿瘤学会(ASPHO)建议,过渡讨论应尽早开始,并作为成年自然过程的一部分进行;患者、医疗服务提供者和家庭都应参与制定过渡计划,并每年评估过渡准备情况;护理交接应包括儿科团队与接受交接的成人医疗服务提供者之间的直接沟通。